Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UNIVERSITY OF ALABAMA AT BIRMINGHAM

NPI: 1154435824 · BIRMINGHAM, AL 35249 · General Acute Care Hospital · NPI assigned 08/18/2006

$19.18M
Total Medicaid Paid
701,711
Total Claims
629,162
Beneficiaries
262
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialJONES, REID (COO UAB HEALTH SYSTEM)
NPI Enumeration Date08/18/2006

Related Entities

Other providers sharing the same authorized official: JONES, REID

ProviderCityStateTotal Paid
UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL $3.22M
UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL $2.68M
PEDIATRIC RADIOLOGY ASSOCIATES, PC BIRMINGHAM AL $301K
UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC BIRMINGHAM AL $135K
UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL $2K
UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC BIRMINGHAM AL $162.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 88,648 $1.48M
2019 101,288 $1.77M
2020 72,856 $1.58M
2021 118,914 $3.54M
2022 115,156 $3.42M
2023 121,682 $4.14M
2024 83,167 $3.24M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J0791 Injection, crizanlizumab-tmca, 5 mg 1,027 864 $5.98M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 98,345 91,680 $3.60M
99284 Emergency department visit for the evaluation and management, high severity 17,398 16,691 $1.16M
99283 Emergency department visit for the evaluation and management, moderate severity 24,450 23,536 $944K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 12,668 11,868 $600K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 66,718 60,640 $564K
99282 Emergency department visit for the evaluation and management, low to moderate severity 12,918 12,411 $543K
80048 Basic metabolic panel (calcium, ionized) 50,566 47,388 $515K
36430 2,528 2,291 $291K
80053 Comprehensive metabolic panel 24,834 20,681 $256K
87086 Culture, bacterial; quantitative colony count, urine 24,316 20,098 $250K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 9,346 8,006 $202K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 651 639 $198K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 15,329 14,595 $192K
83020 12,585 10,147 $176K
36512 1,164 1,065 $133K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,486 1,427 $133K
86850 22,670 19,881 $126K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,830 2,264 $123K
83036 Hemoglobin; glycosylated (A1C) 9,453 8,850 $120K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6,852 6,377 $104K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 1,133 1,085 $101K
80306 7,894 6,774 $94K
64615 535 532 $90K
82728 9,585 8,781 $88K
85027 18,917 15,526 $82K
0001A 2,735 2,515 $79K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,870 969 $78K
0002A 2,337 2,241 $76K
J2785 Injection, regadenoson, 0.1 mg 647 625 $76K
86832 724 574 $70K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,986 1,207 $68K
86833 719 574 $64K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 3,907 3,349 $60K
99233 Prolong inpt eval add15 m 3,459 3,015 $59K
86922 3,524 3,136 $59K
86901 22,568 19,769 $58K
86900 22,299 19,539 $58K
83735 7,772 7,291 $57K
87536 1,757 1,729 $53K
85045 10,313 7,868 $51K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 684 452 $48K
82607 2,884 2,781 $48K
83615 8,449 6,414 $47K
J2997 Injection, alteplase recombinant, 1 mg 843 779 $47K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2,246 2,196 $46K
74183 113 113 $45K
82950 6,518 5,488 $43K
87077 5,695 4,771 $42K
87631 895 820 $38K
82746 2,747 2,645 $34K
84443 Thyroid stimulating hormone (TSH) 2,060 1,988 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,844 1,733 $33K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 429 421 $33K
84466 1,958 1,832 $32K
80076 4,353 4,081 $29K
73610 2,126 1,997 $29K
78451 385 370 $27K
82570 6,042 5,303 $27K
83970 417 412 $26K
81001 7,055 6,708 $26K
83880 905 847 $25K
81025 7,009 6,724 $24K
73630 1,792 1,729 $24K
99281 Emergency department visit for the evaluation and management, self-limited or minor 486 470 $23K
93017 1,233 1,192 $22K
59025 Fetal non-stress test 4,345 3,847 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 408 399 $21K
83540 3,281 3,143 $21K
82565 2,894 2,420 $18K
80061 Lipid panel 1,034 1,020 $18K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 775 700 $18K
84156 5,823 5,112 $18K
87522 Neg quan hep c or qual rna 528 522 $17K
87186 2,182 1,821 $17K
77067 Screening mammography, bilateral, including computer-aided detection 346 340 $17K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 540 489 $16K
31231 81 78 $14K
84450 2,003 1,604 $14K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 98 97 $13K
84484 1,392 1,227 $13K
G0378 Hospital observation service, per hour 114 110 $13K
85610 3,291 3,104 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,603 1,564 $13K
82043 3,053 2,827 $13K
95886 607 581 $12K
80197 2,213 1,774 $12K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 247 241 $12K
83550 1,583 1,503 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 955 926 $11K
91320 84 83 $10K
82977 1,756 1,648 $10K
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg 14 14 $10K
85007 2,356 1,839 $10K
84439 1,121 1,077 $9K
82105 663 651 $9K
86780 510 459 $9K
73502 708 693 $9K
80069 1,676 1,337 $9K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 49 38 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 58 56 $8K
70551 Magnetic resonance imaging, brain; without contrast material 61 61 $8K
36455 44 43 $7K
73564 439 430 $7K
86160 569 557 $7K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 456 181 $6K
71046 Radiologic examination, chest; 2 views 666 644 $6K
62323 37 37 $6K
86902 2,178 1,941 $6K
82951 780 618 $6K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 31 31 $6K
73562 314 307 $5K
36415 Collection of venous blood by venipuncture 3,954 3,391 $5K
76642 163 158 $5K
90686 288 285 $4K
83690 568 547 $4K
73030 408 389 $4K
84702 324 216 $4K
94729 235 224 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 225 219 $4K
0003A 125 123 $4K
73620 333 325 $4K
0053A 92 91 $3K
0124A 90 89 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 136 132 $3K
72110 171 167 $3K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 64 63 $3K
82952 779 617 $3K
91200 41 39 $3K
84681 209 206 $3K
86225 264 260 $3K
94010 310 299 $3K
90480 85 84 $3K
92587 81 79 $3K
76770 72 71 $2K
86677 118 116 $2K
J1170 Injection, hydromorphone, up to 4 mg 2,584 1,436 $2K
85652 621 610 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 171 92 $2K
84134 253 250 $2K
82652 47 47 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete 63 62 $2K
92567 232 221 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 80 75 $2K
92557 81 77 $2K
94727 143 138 $2K
85379 220 209 $2K
74177 Computed tomography, abdomen and pelvis; with contrast material 14 14 $2K
51600 14 13 $2K
74018 148 145 $2K
86140 715 702 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 768 732 $1K
73130 149 137 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 31 29 $1K
95911 16 12 $1K
71045 Radiologic examination, chest; single view 250 232 $1K
86870 96 81 $1K
97161 39 38 $1K
87340 116 113 $1K
73221 14 13 $1K
73110 113 96 $1K
83883 101 73 $1K
36593 17 12 $1K
86706 115 111 $1K
0051A 30 30 $1K
85730 479 459 $1K
96375 Therapeutic injection; each additional sequential IV push 59 48 $1K
92588 29 26 $1K
J0585 Injection, onabotulinumtoxina, 1 unit 672 514 $943.95
82248 203 201 $928.75
J1644 Injection, heparin sodium, per 1000 units 1,799 1,655 $907.90
86803 72 69 $904.32
72100 53 51 $833.90
86905 348 330 $822.96
82172 49 49 $821.88
88142 42 32 $797.21
70450 Computed tomography, head or brain; without contrast material 12 12 $778.61
80305 103 102 $768.87
86923 108 102 $714.31
0072A 20 19 $680.00
85018 247 233 $643.61
0071A 18 17 $640.00
87070 50 48 $630.27
86300 43 38 $608.35
99195 13 13 $600.66
86256 64 60 $564.90
Q3014 Telehealth originating site facility fee 108 106 $561.51
82784 62 58 $548.00
86039 44 43 $493.50
81003 201 193 $479.78
82390 63 59 $459.61
82103 65 61 $448.14
83010 49 49 $436.32
97162 14 14 $434.80
93320 13 13 $373.74
70355 21 18 $373.16
73590 41 36 $370.50
86704 36 36 $358.96
87147 125 104 $303.94
83525 30 30 $303.30
76705 Ultrasound, abdominal, real time with image documentation; limited 37 36 $303.20
93325 13 13 $276.36
81002 158 150 $274.72
73560 16 15 $238.98
80180 93 83 $224.26
J1885 Injection, ketorolac tromethamine, per 15 mg 301 286 $206.44
72052 14 13 $197.68
51797 14 13 $177.90
84165 27 25 $172.26
72190 16 15 $171.80
86038 16 14 $168.20
86592 25 24 $166.78
86790 12 12 $166.77
84460 29 26 $162.58
91010 12 12 $161.76
51784 14 13 $148.20
86200 12 12 $146.00
84100 31 31 $141.00
95885 14 12 $131.00
88304 12 12 $101.34
82040 13 13 $88.00
J1650 Injection, enoxaparin sodium, 10 mg 20 13 $79.20
J0690 Injection, cefazolin sodium, 500 mg 100 83 $78.58
J2405 Injection, ondansetron hydrochloride, per 1 mg 425 390 $76.53
85613 12 12 $60.66
86431 12 12 $56.10
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,304 1,233 $45.11
J3010 Injection, fentanyl citrate, 0.1 mg 1,172 1,116 $43.60
J2704 Injection, propofol, 10 mg 99 96 $30.09
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg 240 223 $29.20
J1030 Injection, methylprednisolone acetate, 40 mg 176 169 $25.84
85014 15 13 $24.29
J2270 Injection, morphine sulfate, up to 10 mg 14 13 $22.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg 208 195 $19.04
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 871 840 $13.45
J2250 Injection, midazolam hydrochloride, per 1 mg 1,430 1,337 $13.26
82962 652 617 $7.26
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 25 24 $6.96
G0008 Administration of influenza virus vaccine 15 15 $4.64
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 41 26 $0.52
0001U 18 18 $0.00
86361 504 498 $0.00
90656 29 29 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 706 678 $0.00
77063 Screening digital breast tomosynthesis, bilateral 319 314 $0.00
C1769 Guide wire 67 49 $0.00
G0475 Hiv antigen/antibody, combination assay, screening 73 70 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 251 249 $0.00
G9172 Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting 12 12 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 38 37 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 38 20 $0.00
74430 14 13 $0.00
93797 41 12 $0.00
G9171 Voice functional limitation, current status at therapy episode outset and at reporting intervals 12 12 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 1,659 1,535 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 53 52 $0.00
P9045 Infusion, albumin (human), 5%, 250 ml 222 204 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 56 56 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 13 12 $0.00
91300 150 149 $0.00
87799 33 28 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 13 12 $0.00